Thomas F. Baumert

Professor or Medicine

University of Strasbourg

France

Research Interests

Explore related searches

Professors in France Professors in Immunology Immunology professors in France

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Thomas F. Baumert is a Professor of Medicine at the University of Strasbourg, France. His research focuses on hepatitis viruses, liver cancer, and liver diseases, exploring areas such as immune evasion, genetic susceptibility, and antiviral therapies. Recent articles highlight his work on hepatitis C virus immune interactions, cholangiocarcinoma treatment, and the role of the gut microbiome in liver transplantation.

Articles (18)

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Collaborators (9)

Seng Gee Lim

SINGAPORE

View details

Mario Pirisi

Università degli Studi del Piemonte Orientale

ITALY

View details

Jane McKeating

Professor

University of Oxford

UNITED KINGDOM

View details

Eloi Verrier

University of Strasbourg

FRANCE

View details

Andrea Magri

University of Oxford

UNITED KINGDOM

View details

Pierre Tonnerre

INSERM

FRANCE

View details

Mala Maini

Professor of Viral Immunology

UCL

UNITED KINGDOM

View details

Che Colpitts

Queen's University

CANADA

View details

Gaëtan Ligat

Associate Professor

Université Paul Sabatier

FRANCE

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Thomas F. Baumert

Research Interests

Explore related searches

Contact this professor

About

Articles (18)

Fine-tuning of hepatitis C virus immune evasion through hypervariable region 1 insertions

Time for arginine methylation: PRMT5 inhibition to advance cholangiocarcinoma treatment

Unraveling the genetic susceptibility to HBV-related liver cancer: The role of virus–host immune interactions

L’horloge circadienne, cible thérapeutique contre la fibrose hépatique

Immunomodulation and entry inhibition: selgantolimod’s double punch against hepatitis B virus

Unraveling the liver antiviral immunity in functional cure of chronic hepatitis B using scRNAseq

JAK1 promotes HDV replication and is a potential target for antiviral therapy

The gut microbiome as a guidepost for infection risk in liver transplantation

The scientific basis of combination therapy for chronic hepatitis B functional cure

Unfolding the mechanism of hepatocyte injury of HBV precore and core promoter variants

Class A capsid assembly modulator RG7907 clears HBV-infected hepatocytes through core-dependent hepatocyte death and proliferation

Unraveling the role of the liver myeloid compartment during hepatitis C virus cure

Tight Junction Protein Signaling and Cancer Biology

Inflammatory Gene Expression Associates with Hepatitis B Virus cccDNA- but Not Integrant-Derived Transcripts in HBeAg Negative Disease

Capsid Assembly Modulators as Antiviral Agents against HBV: Molecular Mechanisms and Clinical Perspectives

Inhibiting cell-to-cell transmission to reach HDV cure: The importance of IFN-α

Signaling Induced by Chronic Viral Hepatitis: Dependence and Consequences

Virus-Induced Risk of Hepatocellular Carcinoma: Recent Progress and Future Challenges

Collaborators (9)

Seng Gee Lim

Mario Pirisi

Jane McKeating

Eloi Verrier

Andrea Magri

Pierre Tonnerre

Mala Maini

Che Colpitts

Gaëtan Ligat

Make your next move.